Archport Ltd was established in 1998 at Dublin City University to provide contract production and development services to the biopharmaceutical industry. The company's range of services include GMP-compliant animal cell culture and downstream processing activities for development or manufacture of active pharmaceutical ingredients (APIs). Products can be for clinical trial or market supply and typical application areas are recombinant proteins, cell therapy products and monoclonal antibodies. Archport also provides services for scale-up of mammalian/insect cell culture, purification processes and joint R&D services.
Within September 2007 Archport Ltd. was introduced under its new name BioUETIKON Ltd to the market.
CU Chemie Uetikon GmbH based in Lahr, Germany, provides production partnership for the pharmaceutical industry. With a proud reputation for providing the highest standards of quality, reliability, confidentiality and financial strength, Uetikon supports its customers with capacity ranging from grams through multi-kilo to multi-ton scale.
Its main business activities include Custom Synthesis, production of Generic API's and Orphan Drugs, and delivery of various key intermediates and specialty chemicals.
A new multi-purpose state-of-the-art GMP plant guarantees the highest level of quality and GMP-compliance. All operations are successfully FDA inspected.
For more information please contact:
BioUETIKON Ltd Head Office,
R & D Building,
DCU,
Dublin 9, Ireland
T: +353 (0) 1 700 7007
F: +353 (0) 1 700 7008
Email: info@biouetikon.com
Homepage: info@biouetikon.com
BioUETIKON Ltd USA Office,
121 Stryker Lane,
Bld. 30 Suite #2,
Hilsborough, NJ 0884, USA
Contact: Mr. David Faghani
T: +1 9088747744
F: +1 9088747731
Email: info@biouetikon.com
